Remifentanil 	Fentanyl/midazolam	Respiratory adverse events	11852	11919	Respiratory adverse event was not experienced in any of the groups.
Remifentanil 	Fentanyl/midazolam	Satisfaction 	984	1242	Remifentanil group had lower duration of procedure (2.5 ± 1.6 versus 4.6 ± 1.8 minutes, p < 0.001), higher pain reduction (53.7 ± 13.3 versus 33.5 ± 19.6, p < 0.001), lower failure rate (1 (2.1%) versus 15 (31.3%), p < 0.001), higher satisfaction (p = 0.005)
Remifentanil 	Fentanyl/midazolam	Respiratory adverse events	11852	11918	Respiratory adverse event was not experienced in any of the groups
Remifentanil 	Fentanyl/midazolam	Non- respiratory adverse events	11920	12058	Non-respiratory adverse events were seen in 12 (25%) patients in midazolam/fentanyl and 8 (16.7%) cases in remifentanil group (p = 0.122).
Remifentanil 	Fentanyl/midazolam	Duration of procedure	982	1083	. Remifentanil group had lower duration of procedure (2.5 ± 1.6 versus 4.6 ± 1.8 minutes, p < 0.001),
Remifentanil 	Fentanyl/midazolam	Satisfaction 	984	1243	Remifentanil group had lower duration of procedure (2.5 ± 1.6 versus 4.6 ± 1.8 minutes, p < 0.001), higher pain reduction (53.7 ± 13.3 versus 33.5 ± 19.6, p < 0.001), lower failure rate (1 (2.1%) versus 15 (31.3%), p < 0.001), higher satisfaction (p = 0.005).
Remifentanil 	Fentanyl/midazolam	Failure rate 	984	1243	Remifentanil group had lower duration of procedure (2.5 ± 1.6 versus 4.6 ± 1.8 minutes, p < 0.001), higher pain reduction (53.7 ± 13.3 versus 33.5 ± 19.6, p < 0.001), lower failure rate (1 (2.1%) versus 15 (31.3%), p < 0.001), higher satisfaction (p = 0.005).
Remifentanil 	Fentanyl/midazolam	Duration of procedure	984	1243	Remifentanil group had lower duration of procedure (2.5 ± 1.6 versus 4.6 ± 1.8 minutes, p < 0.001), higher pain reduction (53.7 ± 13.3 versus 33.5 ± 19.6, p < 0.001), lower failure rate (1 (2.1%) versus 15 (31.3%), p < 0.001), higher satisfaction (p = 0.005).
Remifentanil 	Fentanyl/midazolam	Pain	984	1243	Remifentanil group had lower duration of procedure (2.5 ± 1.6 versus 4.6 ± 1.8 minutes, p < 0.001), higher pain reduction (53.7 ± 13.3 versus 33.5 ± 19.6, p < 0.001), lower failure rate (1 (2.1%) versus 15 (31.3%), p < 0.001), higher satisfaction (p = 0.005).
